 PHASE IIA SAFETY AND LIGHT DOSE-ESCALATION STUDY IN PATIENTS WITH PRIMARY OR RECURRENTHIGH-GRADE GLIOMA USING THE LITXTM SYSTEM TO CONFIRM THE ZONE OF TUMOR DESTRUCTION DURING THE INTRAOPERATIVE TREATMENT OF GLIOMA: 